1 |
Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al |
1:23-cv-00582 |
D.Del. |
|
|
|
|
2 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
3 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
4 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
5 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
6 |
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al |
1:23-cv-00926 |
D.N.J. |
|
|
|
|
7 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
8 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
9 |
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al |
1:23-cv-00039 |
D.Del. |
|
|
|
|
10 |
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01391 |
D.Del. |
|
|
|
|
11 |
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01391 |
D.Del. |
|
|
|
|
12 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
13 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
14 |
Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. |
1:22-cv-01365 |
D.Del. |
|
|
|
|
15 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|
16 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|
17 |
Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al |
1:22-cv-01270 |
D.Del. |
|
|
|
|
18 |
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al |
1:22-cv-00971 |
D.Del. |
|
|
|
|
19 |
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al |
1:22-cv-00971 |
D.Del. |
|
|
|
|
20 |
BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al |
3:22-cv-02345 |
D.N.J. |
|
|
|
|
21 |
BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al |
3:22-cv-02345 |
D.N.J. |
|
|
|
|
22 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
23 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
24 |
Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al |
1:20-cv-00632 |
D.Del. |
|
|
|
|
25 |
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. |
1:20-cv-03102 |
D.N.J. |
|
|
|
|
26 |
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. |
1:20-cv-03102 |
D.N.J. |
|
|
|
|
27 |
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. |
1:20-cv-03102 |
D.N.J. |
|
|
|
|
28 |
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. |
1:20-cv-03102 |
D.N.J. |
|
|
|
|
29 |
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. |
1:20-cv-03102 |
D.N.J. |
|
|
|
|